AU2011343008A1 - Vaccine - Google Patents

Vaccine Download PDF

Info

Publication number
AU2011343008A1
AU2011343008A1 AU2011343008A AU2011343008A AU2011343008A1 AU 2011343008 A1 AU2011343008 A1 AU 2011343008A1 AU 2011343008 A AU2011343008 A AU 2011343008A AU 2011343008 A AU2011343008 A AU 2011343008A AU 2011343008 A1 AU2011343008 A1 AU 2011343008A1
Authority
AU
Australia
Prior art keywords
modified
dtxr
pseudotuberculosis
corynebacterium
microorganism
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2011343008A
Other languages
English (en)
Inventor
Michael Fontaine
Caray Walker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Moredun Research Institute
Original Assignee
Moredun Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Moredun Research Institute filed Critical Moredun Research Institute
Publication of AU2011343008A1 publication Critical patent/AU2011343008A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU2011343008A 2010-12-13 2011-12-13 Vaccine Abandoned AU2011343008A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB201021096A GB201021096D0 (en) 2010-12-13 2010-12-13 Vaccine
GB1021096.1 2010-12-13
PCT/GB2011/001716 WO2012080696A1 (fr) 2010-12-13 2011-12-13 Vaccin

Publications (1)

Publication Number Publication Date
AU2011343008A1 true AU2011343008A1 (en) 2013-07-25

Family

ID=43567095

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2011343008A Abandoned AU2011343008A1 (en) 2010-12-13 2011-12-13 Vaccine

Country Status (4)

Country Link
EP (1) EP2651438A1 (fr)
AU (1) AU2011343008A1 (fr)
GB (1) GB201021096D0 (fr)
WO (1) WO2012080696A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201209014D0 (en) * 2012-05-22 2012-07-04 Moredun Res Inst Vaccine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0554335A4 (en) * 1990-10-25 1994-09-14 Commw Scient Ind Res Org Corynebacteria and related organisms as vaccine vectors
WO2001030384A1 (fr) * 1999-10-22 2001-05-03 Advanced Microbial Solutions Corporation Compositions de vaccin

Also Published As

Publication number Publication date
GB201021096D0 (en) 2011-01-26
WO2012080696A1 (fr) 2012-06-21
EP2651438A1 (fr) 2013-10-23

Similar Documents

Publication Publication Date Title
Tidhar et al. The NlpD lipoprotein is a novel Yersinia pestis virulence factor essential for the development of plague
Karna et al. CsrA modulates levels of lipoproteins and key regulators of gene expression critical for pathogenic mechanisms of Borrelia burgdorferi
JP2008022856A (ja) 肺炎連鎖球菌由来の核酸及びタンパク質
US11717565B2 (en) Recombinant BCG overexpressing phoP-phoR
Hsueh et al. Evaluation on a S treptococcus suis Vaccine Using Recombinant S ao‐L Protein Manufactured by Bioreactors as the Antigen in Pigs
Lizano et al. Role of streptococcal T antigens in superficial skin infection
Okwumabua et al. Identification of the gene encoding a 38-kilodalton immunogenic and protective antigen of Streptococcus suis
He et al. Recombinant Ochrobactrum anthropi expressing Brucella abortus Cu, Zn superoxide dismutase protects mice against B. abortus infection only after switching of immune responses to Th1 type
Clow et al. PilVax, a novel Lactococcus lactis‐based mucosal vaccine platform, stimulates systemic and mucosal immune responses to Staphylococcus aureus
Wu et al. A Streptococcus suis LysM domain surface protein contributes to bacterial virulence
Sahin et al. Key role of capsular polysaccharide in the induction of systemic infection and abortion by hypervirulent Campylobacter jejuni
Bull et al. A novel multi-antigen virally vectored vaccine against Mycobacterium avium subspecies paratuberculosis
Feng et al. Immunogenicity and protective capacity of EF-Tu and FtsZ of Streptococcus suis serotype 2 against lethal infection
Okuda et al. The toxR gene of Vibrio (Listonella) anguillarum controls expression of the major outer membrane proteins but not virulence in a natural host model
Chen et al. Immunogenicity and efficacy of two DNA vaccines encoding antigenic PspA and TerD against Nocardia seriolae in hybrid snakehead
JP2016513078A (ja) 一段階または多段階のトリ型結核菌亜種副結核症サブユニット・ワクチン
WO2006130925A1 (fr) Manipulation genetique de clostridium difficile
Casselli et al. A small intergenic region of lp17 is required for evasion of adaptive immunity and induction of pathology by the Lyme disease spirochete
CN108330142B (zh) 一种具有免疫保护作用的美人鱼发光杆菌溶血素Hlych蛋白
Chelliah et al. Potential DNA vaccine for haemorrhagic septiceamia disease
Wu et al. Identification and testing of Porphyromonas gingivalis virulence genes with a pPGIVET system
Swain et al. Construction and Evaluation of Recombinant Attenuated Edwardsiella piscicida Vaccine (RAEV) Vector System Encoding Ichthyophthirius multifiliis (Ich) Antigen IAG52B
AU2011343008A1 (en) Vaccine
WO2018022974A1 (fr) Souches sérovar typhimurium de salmonella modifiées, compositions de celles-ci et procédés d'utilisation
Tang et al. Identification of a surface protective antigen, MAP of Streptococcus equi subspecies zooepidemicus

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted